Hollencrest Capital Management Abbott Laboratories Transaction History

Hollencrest Capital Management

$2.36 Billion
Q3 2024

A detailed history of Hollencrest Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Hollencrest Capital Management holds 1,567 shares of ABT stock, worth $179,828. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,567

Previous 1,561 0.38%

Holding current value

$179,828

Previous $162,000 9.88%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$100.07 - $118.13 $600 - $708	6 Added 0.38%	1,567 $178,000
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $385,072 - $425,295	-3,516 Reduced 69.25%	1,561 $177,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $10,508 - $12,608	-110 Reduced 2.12%	5,077 $491,000
Q1 2023 May 16, 2023	BUY	$96.86 - $114.01 $340,559 - $400,859	3,516 Added 210.41%	5,187 $525,000
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $158,845 - $186,349	1,671 New	1,671 $183,000
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $195,566 - $236,376	-1,916 Closed	0 $0
Q1 2022 Apr 18, 2022	SELL	$114.02 - $139.04 $1,026 - $1,251	-9 Reduced 0.47%	1,916 $226,000
Q4 2021 Jan 07, 2022	SELL	$115.53 - $141.46 $184,732 - $226,194	-1,599 Reduced 45.37%	1,925 $270,000
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $116 - $129	1 Added 0.03%	3,524 $416,000
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $44,326 - $52,178	-419 Reduced 10.63%	3,523 $409,000
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $14,366 - $16,926	-132 Reduced 3.24%	3,942 $472,000
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $25,200 - $27,460	-240 Reduced 5.56%	4,074 $446,000
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $1,191 - $1,446	13 Added 0.3%	4,314 $469,000
Q2 2020 Jul 16, 2020	SELL	$76.57 - $98.0 $2,220 - $2,842	-29 Reduced 0.67%	4,301 $394,000
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $9,611 - $14,054	153 Added 3.66%	4,330 $342,000
Q4 2019 Jan 23, 2020	BUY	$78.51 - $87.4 $628 - $699	8 Added 0.19%	4,177 $363,000
Q3 2019 Oct 23, 2019	BUY	$81.84 - $88.74 $8,756 - $9,495	107 Added 2.63%	4,169 $349,000
Q2 2019 Jul 18, 2019	BUY	$72.88 - $85.0 $19,604 - $22,865	269 Added 7.09%	4,062 $342,000
Q4 2018 May 09, 2019	BUY	$65.56 - $74.27 $524 - $594	8 Added 0.21%	3,793 $274,000
Q4 2018 Jan 03, 2019	SELL	$65.56 - $74.27 $524 - $594	-8 Reduced 0.21%	3,785 $274,000
Q3 2018 May 09, 2019	BUY	$60.81 - $73.36 $9,607 - $11,590	158 Added 4.35%	3,793 $303,000
Q3 2018 Oct 04, 2018	SELL	$60.81 - $73.36 $20,979 - $25,309	-345 Reduced 8.67%	3,635 $267,000
Q2 2018 Jul 10, 2018	SELL	$57.57 - $63.54 $216,693 - $239,164	-3,764 Reduced 48.61%	3,980 $0
Q1 2018 Apr 24, 2018	BUY	$56.27 - $63.62 $25,771 - $29,137	458 Added 6.29%	7,744 $464,000
Q4 2017 Jan 19, 2018	SELL	$53.68 - $57.47 $2,200 - $2,356	-41 Reduced 0.56%	7,286 $0
Q3 2017 Oct 10, 2017	BUY	$48.06 - $53.64 $352,135 - $393,020	7,327	7,327 $391,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Account

Hollencrest Capital Management Abbott Laboratories Transaction History